244 related articles for article (PubMed ID: 35300001)
1. Protocol for isolation and functional validation of label-retaining quiescent colorectal cancer stem cells from patient-derived organoids for RNA-seq.
Regan JL
STAR Protoc; 2022 Mar; 3(1):101225. PubMed ID: 35300001
[TBL] [Abstract][Full Text] [Related]
2. Protocol for serial organoid formation assay using primary colorectal cancer tissues to evaluate cancer stem cell activity.
Bergin CJ; Benoit YD
STAR Protoc; 2022 Mar; 3(1):101218. PubMed ID: 35265864
[TBL] [Abstract][Full Text] [Related]
3. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
[TBL] [Abstract][Full Text] [Related]
4. Protocol for functional profiling of patient-derived organoids for precision oncology.
Nemati N; Boeck N; Lamberti G; Lisandrelli R; Trajanoski Z
STAR Protoc; 2024 Mar; 5(1):102887. PubMed ID: 38367233
[TBL] [Abstract][Full Text] [Related]
5. RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence.
Regan JL; Schumacher D; Staudte S; Steffen A; Lesche R; Toedling J; Jourdan T; Haybaeck J; Mumberg D; Henderson D; Győrffy B; Regenbrecht CRA; Keilholz U; Schäfer R; Lange M
iScience; 2021 Jun; 24(6):102618. PubMed ID: 34142064
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and single-cell RNA-seq analyses of human pluripotent-stem-cell-derived renal organoids.
Lian E; Pietrobon A; Stanford WL
STAR Protoc; 2023 May; 4(2):102314. PubMed ID: 37220001
[TBL] [Abstract][Full Text] [Related]
7. Tracking the growth fate of single cells and isolating slow-growing cells in human colorectal cancer organoids.
Coppo R; Kondo J; Onuma K; Inoue M
STAR Protoc; 2023 Sep; 4(3):102395. PubMed ID: 37384521
[TBL] [Abstract][Full Text] [Related]
8. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer.
Norkin M; Ordóñez-Morán P; Huelsken J
Cell Rep; 2021 Apr; 35(3):109026. PubMed ID: 33882314
[TBL] [Abstract][Full Text] [Related]
9. Protocol for Efficient Protein Synthesis Detection by Click Chemistry in Colorectal Cancer Patient-Derived Organoids Grown
Morral C; Stanisavljevic J; Batlle E
STAR Protoc; 2020 Sep; 1(2):100103. PubMed ID: 33000005
[TBL] [Abstract][Full Text] [Related]
10. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
Ding L; Yang Y; Lu Q; Cao Z; Weygant N
Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
[TBL] [Abstract][Full Text] [Related]
11. Optimized protocol for analysis of neural stem proliferation in human-pluripotent-stem-cell-derived cerebral organoids.
Tang XY; Wang D; Zhang XY; Xu M; Liu Y
STAR Protoc; 2023 Mar; 4(2):102169. PubMed ID: 36924505
[TBL] [Abstract][Full Text] [Related]
12. FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter.
Di Franco S; Zhang L; Gaggianesi M; Lo Iacono M; Medema JP; Stassi G
STAR Protoc; 2021 Dec; 2(4):100880. PubMed ID: 34712995
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
Okamoto T; duVerle D; Yaginuma K; Natsume Y; Yamanaka H; Kusama D; Fukuda M; Yamamoto M; Perraudeau F; Srivastava U; Kashima Y; Suzuki A; Kuze Y; Takahashi Y; Ueno M; Sakai Y; Noda T; Tsuda K; Suzuki Y; Nagayama S; Yao R
Stem Cell Reports; 2021 Apr; 16(4):954-967. PubMed ID: 33711267
[TBL] [Abstract][Full Text] [Related]
14. Protocol to dissociate, process, and analyze the human lung tissue using single-cell RNA-seq.
Quintanal-Villalonga Á; Chan JM; Masilionis I; Gao VR; Xie Y; Allaj V; Chow A; Poirier JT; Pe'er D; Rudin CM; Mazutis L
STAR Protoc; 2022 Dec; 3(4):101776. PubMed ID: 36313536
[TBL] [Abstract][Full Text] [Related]
15. Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids.
Wu Y; Li K; Li Y; Sun T; Liu C; Dong C; Zhao T; Tang D; Chen X; Chen X; Liu P
Nucleic Acids Res; 2022 Mar; 50(5):e28. PubMed ID: 34893868
[TBL] [Abstract][Full Text] [Related]
16. Whole-mount staining of mouse colorectal cancer organoids and fibroblast-organoid co-cultures.
Martinez-Ordoñez A; Cid-Diaz T; Duran A; Han Q; Moscat J; Diaz-Meco MT
STAR Protoc; 2023 Apr; 4(2):102243. PubMed ID: 37083323
[TBL] [Abstract][Full Text] [Related]
17. Protocol for RNA-seq library preparation starting from a rare muscle stem cell population or a limited number of mouse embryonic stem cells.
Dell'Orso S; Juan AH; Moiseeva V; García-Prat L; Muñoz-Cánoves P; Sartorelli V
STAR Protoc; 2021 Jun; 2(2):100451. PubMed ID: 33937872
[TBL] [Abstract][Full Text] [Related]
18. Protocol to identify and analyze mouse and human quiescent hematopoietic stem cells using flow cytometry combined with confocal imaging.
Qiu J; Menon V; Tzavaras N; Liang R; Ghaffari S
STAR Protoc; 2022 Dec; 3(4):101828. PubMed ID: 36595934
[TBL] [Abstract][Full Text] [Related]
19. Murine cochlear cell sorting and cell-type-specific organoid culture.
Kubota M; Heller S
STAR Protoc; 2021 Sep; 2(3):100645. PubMed ID: 34278332
[TBL] [Abstract][Full Text] [Related]
20. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
Tan T; Mouradov D; Gibbs P; Sieber OM
STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
